Pneumonia Testing Market Size & Share, by Types (Consumables, Analyzers); Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing); End-user (Hospitals, Diagnostic Laboratories, Home Care) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4457
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Pneumonia Testing Landscape

top-features-companies
    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • bioMérieux SA
    • INTEC
    • OpGen
    • BD (Becton, Dickinson, and Company)
    • Meridian Bioscience, Inc.
    • Luminex Corporation (DiaSorin S.p.A.)
    • F. Hoffmann-La Roche Ltd.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • bioMérieux, a global leader in invitro diagnostics, unveils that it has reached an agreement to procure Specific Diagnostics, a privately held American Company that has created a rapid antimicrobial susceptibility test (AST) system that provides phenotypic AST directly from positive blood cultures.

  • A corporation among DiaSorin (FTSE MIB: DIA) and B.R.A.H.M.S. GmbH, a division of Thermo Fisher Scientific, has been formed with the goal of developing and marketing the novel LIAISON B.R.A.H.M.S MR-proADM immunodiagnostic test. The test can assist in the detection of several serious illnesses, including sepsis, septic shock, lower respiratory infections, urinary tract infections, and kidney disease.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4457
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of COVID-19, Increasing incidence of hospital-acquired pneumonia (HAP), growing geriatric population, and advancement of POCT and nucleic acid detection tests.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.

Widespread utilization of x-rays to detect pneumonia, high cost of testing devices and traditional approach of culturing is detained and prone to inaccuracy.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Abbott, Quidel Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, INTEC, OpGen, BD (Becton, Dickinson, and Company), Meridian Bioscience, Inc., Luminex Corporation (DiaSorin S.p.A.), F.Hoffmann-La Roche Ltd, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, method, end user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying